Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Burning Rock Biotech Limited
  6. News
  7. Summary
    BNR   US12233L1070

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
2.380 USD    0.00%
05/16Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
GL
05/16Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
AQ
03/22BURNING ROCK BIOTECH : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 6-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Burning Rock Biotech Reaffirms 2021 Revenue Target

12/29/2021 | 04:11am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about BURNING ROCK BIOTECH LIMITED
05/16Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
GL
05/16Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
AQ
03/22BURNING ROCK BIOTECH : Reports Fourth Quarter and Full Year 2021 Financial Results - Form ..
PU
03/22Burning Rock Biotech Limited Reports Earnings Results for the Full Year Ended December ..
CI
03/22TRANSCRIPT : Burning Rock Biotech Limited, Q4 2021 Earnings Call, Mar 22, 2022
CI
03/22Burning Rock Biotech's Q4 Loss Widens, Revenue Rises
MT
03/21BURNING ROCK BIOTECH : Q4 2021 Presentation Slides
PU
03/21Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
GL
03/21Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
GL
03/21Burning Rock Biotech Limited Provides Revenue Guidance for the Year 2022
CI
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Financials
Sales 2022 620 M 92,5 M 92,5 M
Net income 2022 -656 M -97,9 M -97,9 M
Net cash 2022 673 M 100 M 100 M
P/E ratio 2022 -2,56x
Yield 2022 -
Capitalization 1 677 M 250 M 250 M
EV / Sales 2022 1,62x
EV / Sales 2023 0,49x
Nbr of Employees 1 394
Free-Float 67,9%
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 15,94 CNY
Average target price 84,82 CNY
Spread / Average Target 432%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Technology Officer
Wendy Hayes Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BURNING ROCK BIOTECH LIMITED-75.03%250
SONIC HEALTHCARE LIMITED-21.70%12 399
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-29.96%5 423
SYNLAB AG-23.03%4 288
DR. LAL PATHLABS LIMITED-42.32%2 348
DIAGNOSTICOS DA AMÉRICA S.A.-41.29%2 329